IP Library Granted Patent US 8,551,069
Granted Patent B2
US 8,551,069 · App. 11/368,809 · Granted Oct 8, 2013

Methods and apparatus for treating contrast nephropathy

Inventors: Denise Demarais (Los Gatos, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Douglas Sutton (Pacifica, CA)
Assignee: Medtronic Adrian Luxembourg S.a.r.l.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,069
App. No.
11/368,809
Granted
Oct 8, 2013
Kind
B2
Abstract

Methods and apparatus are provided for treating contrast nephropathy, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Claims (25)

1. A method for treating contrast nephropathy, the method comprising:

Introducing modulation apparatus to a vicinity of a neural fiber that contributes to renal function of a kidney of a patient that is experiencing contrast nephropathy; and

modulating a function of the neural fiber via the modulation apparatus;

wherein modulating the function of the neural fiber further comprises modulating the function without completely physically severing the neural fiber.

2. The method of claim 1 , wherein modulating the function of the neural fiber via the neuromodulation apparatus further comprises modulating the function of the neural fiber via an electric field.

3. The method of claim 2 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a pulsed electric field.

4. The method of claim 2 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a stimulation electric field.

5. The method of claim 1 , wherein modulating the function of the neural fiber further via the neuromodulation apparatus comprises delivering a neuromodulatory agent to the neural fiber.

6. The method of claim 1 , wherein modulating the function of the neural fiber via the neuromodulation apparatus further comprises at least partially denervating the kidney.

7. The method of claim 1 , wherein modulating the function of the neural fiber via the neuromodulation apparatus further comprises inducing an effect in the neural fiber chosen from the group consisting of irreversible electroporation, electrofusion, necrosis, apoptosis, gene expression alteration, cytokine up-regulation alteration, and combinations thereof.

8. The method of claim 1 , wherein modulating the function of the neural fiber via the neuromodulation apparatus further comprises thermally modulating the function of the neural fiber.

9. The method of claim 1 , wherein modulating the function of the neural fiber via the neuromodulation apparatus further comprises modulating the function of the neural fiber with high frequency ultrasound.

10. A method for treating contrast nephropathy, the method comprising:

Percutaneously introducing modulation apparatus to a vicinity of a neural fiber that contributes to renal function of a kidney of a patient that is experiencing contrast nephropathy; and

modulating a function of the neural fiber via the modulation apparatus.

11. The method of claim 10 , wherein percutaneously introducing modulation apparatus further comprises introducing the modulation apparatus via a laparoscopic approach.

12. The method of claim 10 , wherein percutaneously introducing modulation apparatus further comprises introducing the modulation apparatus via an endoluminal approach.

13. The method of claim 10 , wherein modulating the function of the neural fiber via the modulation apparatus further comprises modulating the function of the neural fiber via an electric field.

14. The method of claim 13 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a pulsed electric field.

15. The method of claim 13 , wherein modulating the function of the neural fiber via an electric field further comprises exposing the neural fiber to a stimulation electric field.

16. The method of claim 10 , wherein modulating the function of the neural fiber via the modulation apparatus further comprises delivering a neuromodulatory agent to the neural fiber.

17. The method of claim 10 , wherein modulating the function of the neural fiber via the modulation apparatus further comprises at least partially denervating the kidney.

18. The method of claim 10 , wherein modulating the function of the neural fiber via the modulation apparatus further comprises inducing an effect in the neural fiber chosen from the group consisting of irreversible electroporation, electrofusion, necrosis, apoptosis, gene expression alteration, cytokine up-regulation alteration, and combinations thereof.

19. The method of claim 10 , wherein modulating the function of the neural fiber via the modulation apparatus further comprises thermally modulating the function of the neural fiber.

20. The method of claim 10 , wherein modulating the function of the neural fiber via the modulation apparatus further comprises modulating the function of the neural fiber with high frequency ultrasound.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 030286/0213 →
CHANGE OF NAME Recorded Apr 25, 2013
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 030293/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2006
From: DEMARAIS, DENISE; GIFFORD, III, HANSON; DEEM, MARK; SUTTON, DOUGLAS
To: ARDIAN, INC.
Reel/Frame 018139/0863 →
Continuity (17)
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11133925 · May 20, 2005
Continuation 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11266993 · Nov 4, 2005
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60813589 · Dec 29, 2005
Related Publication 20060271111A1 · Nov 30, 2006